Clinical research group Icon has reported net profits of $9.3m for its second quarter to the end of June, up from $5.9m in the equivalent period last year. Net sales grew by 25% to $107.4m, better than expected.
Operating profits rose by 68% to $12.4m, while the company won $166m of new business in the quarter, an increase of 64%.
As a result, Icon has raised its forecast for revenue for the full year by $30m. to a range of $425-440m.
Shares in the company closed up 8% to €47.18 in Dublin this evening.
